GlassScriptPhysician profile
Adrienne Nelson
NPI 1477105732
$9,162.16
in general payments reported to CMS, 2019-2025
42 companies · $2,535 in 2025
The $2,535 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,130 · 2023: $2,302 · 2024: $2,195 · 2025: $2,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,031.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,409.69 | 2022-2025 | |
| Celgene Corporation | $597.48 | 2022-2025 | Zeposia |
| Ucb, INC. | $452.60 | 2022-2025 | Briviact, Rystiggo, Nayzilam |
| Biogen, INC. | $432.62 | 2022-2025 | Tysabri, Vumerity |
| Emd Serono, INC. | $393.64 | 2023-2025 | Mavenclad |
| Amneal Pharmaceuticals LLC | $375.19 | 2022-2025 | Rytary, Crexont, Ongentys |
| Sk Life Science, INC. | $372.74 | 2022-2024 | Xcopri |
| Harmony Biosciences LLC | $345.66 | 2022-2025 | Wakix |
| Pfizer INC. | $344.32 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $335.10 | 2022-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $256.43 | 2022-2025 | Vyepti, Rexulti |
| Novartis Pharmaceuticals Corporation | $251.00 | 2023-2025 | |
| Argenx US, INC. | $237.10 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Acadia Pharmaceuticals INC | $207.42 | 2022-2025 | Nuplazid |
| Axsome Therapeutics, INC. | $203.21 | 2024-2025 | Sunosi, Symbravo |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrienne Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.